Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels

INTRODUCTION: Levosimendan is approved for acute heart failure. Within this context, pulmonary hypertension represents a frequent co-morbidity. Hence, the effects of levosimendan on segmental pulmonary vascular resistance (PVR) are relevant. So far, this issue has been not studied. Beyond that the r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Rieg, Annette Dorothea, Suleiman, Said, Bünting, Nina Andrea, Verjans, Eva, Spillner, Jan, Schnöring, Heike, Kalverkamp, Sebastian, Schröder, Thomas, von Stillfried, Saskia, Braunschweig, Till, Schälte, Gereon, Uhlig, Stefan, Martin, Christian
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7233573/
https://ncbi.nlm.nih.gov/pubmed/32421724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233176
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki